Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2040409

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2040409

Neurovascular Microcatheter Market Size, Share, & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Neurovascular Microcatheter Market Summary

The global neurovascular microcatheter market size was valued at USD 703.98 million in 2025 and is projected to reach USD 1,224.73 million by 2033, growing at a CAGR of 7.07% from 2026 to 2033. The industry is driven by the rising prevalence of neurovascular aneurysms, which is increasing demand for minimally invasive procedures such as coiling and flow diversion, where precise catheter navigation is essential.

In addition, the growing incidence of ischemic stroke is a major factor, as these devices are widely used in mechanical thrombectomy procedures to restore blood flow quickly and effectively. The expanding global burden of stroke, particularly among aging populations, further supports market growth. Moreover, the rising cases of hypertension, a key risk factor for both aneurysms and strokes, are contributing to a larger patient pool requiring neurovascular interventions, thereby boosting the demand for advanced microcatheter technologies and supporting overall market expansion globally.

The rising prevalence of neurovascular aneurysms is growing the market for neurovascular microcatheters, as it significantly increases the demand for minimally invasive treatment procedures. Cerebral aneurysms, if left untreated, can rupture and lead to severe complications such as hemorrhagic stroke, prompting early diagnosis and timely intervention. This has led to an increasing number of endovascular procedures, including coil embolization and flow diversion, where microcatheters are essential for precise navigation through complex cerebral vessels. According to the Hereditary Brain Aneurysm Support 2025, unruptured brain aneurysms, localized bulges or swellings in the brain's blood vessels, are relatively common, affecting about 3% of the UK population, or roughly 2 million people. While most aneurysms remain asymptomatic and do not cause problems, a small number, between 3,000 and 5,000 cases each year, rupture, with approximately half of these resulting in fatal outcomes. In addition, advancements in imaging technologies and increasing awareness among patients and healthcare providers have improved early detection rates. The shift toward minimally invasive techniques, due to reduced recovery time and lower procedural risks, is further accelerating adoption.

"Brain aneurysms typically produce no symptoms but can burst without warning with catastrophic consequences. The reality is that most brain aneurysms will never rupture, but we currently have no way of identifying the minority that will. We are making great strides in understanding clinical risk factors but our ability to understand the genetics behind their development and understand why they rupture remains surprisingly limited for a condition that potentially impacts 3% of the UK population."- Professor Diederik Bulters, Consultant Neurosurgeon at UHS, Honorary Professor of Neurovascular Surgery at the University of Southampton, and Chief Investigator of the ROAR Study.

The rising prevalence of stroke is growing the market for neurovascular microcatheters, as it significantly increases the need for timely and effective treatment interventions. Ischemic strokes, which account for the majority of cases, require procedures such as mechanical thrombectomy to restore blood flow to the brain quickly. Neurovascular microcatheters play a vital role in these procedures by enabling precise navigation through complex cerebral arteries and supporting accurate device delivery. The increasing incidence of stroke, driven by aging populations and lifestyle-related risk factors such as hypertension, diabetes, and obesity, is leading to a higher number of interventional procedures. In addition, growing awareness about early stroke management and improved healthcare infrastructure are further boosting the adoption of neurovascular microcatheters, thereby driving market growth.

Technological advancements are driving the neurovascular microcatheter market by significantly improving the performance, safety, and precision of endovascular procedures. Innovations such as enhanced flexibility, smaller diameters, improved trackability, and hydrophilic coatings enable microcatheters to navigate complex, tortuous cerebral vessels with greater ease and accuracy. In 2025, Researchers at EPFL developed an extremely small, highly flexible neurovascular microcatheter that can navigate complex, branching blood vessels with ease. Uniquely, the device is driven by natural blood flow, allowing it to travel quickly and safely through intricate arterial pathways, improving navigation and reducing the risk during neurovascular procedures.

"Catheters eliminate concerns about device removal after use, and don't have limited payloads. At the same time, many blood vessels lie beyond a traditional catheter's reach," Sakar explains. "That's why we have developed and tested MagFlow: an ultraminiaturized magnetic microcatheter - twice as small as benchmark microcatheters - that minimizes contact with vessel walls by hitching a ride on the blood stream's own kinetic energy." - head of the MicroBioRobotic Systems Laboratory in EPFL's School of Engineering

The development of dual-lumen, steerable microcatheters further enables better control and targeted delivery of therapeutic devices during procedures such as coil embolization and thrombectomy. In addition, integration with advanced imaging systems and real-time navigation technologies enhances procedural outcomes and reduces risks. These continuous improvements are increasing physician confidence, expanding the scope of minimally invasive treatments, and driving the adoption of neurovascular microcatheters across healthcare settings.

Global Neurovascular Microcatheter Market Report Segmentation

This report forecasts global, regional, and country-level revenue growth and analyzes the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurovascular microcatheter market report on the basis of type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Single-Lumen Microcatheters
  • Dual-Lumen Balloon Microcatheters
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic Delivery
  • Therapeutic Embolization Delivery
  • Temporary Occlusion / Flow Control
  • Vascular Access & Navigation
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Product Code: GVR-4-68040-888-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Neurovascular Microcatheter Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of neurovascular diseases
      • 3.2.1.2. Increasing adoption of minimally invasive neurovascular procedures
      • 3.2.1.3. Technological advancements in microcatheters
      • 3.2.1.4. Expansion of neurointerventional infrastructure and catheterization laboratories
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of neurovascular procedures and devices
      • 3.2.2.2. Stringent regulatory approval processes for neurovascular devices
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Increasing adoption of outpatient and ambulatory surgical centers
      • 3.2.3.2. Growing demand in emerging markets s
      • 3.2.3.3. Rising research and development investments in neurovascular devices
      • 3.2.3.4. Increasing awareness and early diagnosis of neurological disorders
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Complexity of neurovascular procedures
      • 3.2.4.2. High training requirements for physicians
  • 3.3. Neurovascular Microcatheter Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Microcatheter Market: Type (Capacity / Model-Based) Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurovascular Microcatheter Market: Type Movement Analysis
  • 4.3. Neurovascular Microcatheter Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Single-Lumen Microcatheters
    • 4.5.1. Single-Lumen Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Dual-Lumen Balloon Microcatheters
    • 4.6.1. Dual-Lumen Balloon Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurovascular Microcatheter Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurovascular Microcatheter Market: Application Movement Analysis
  • 5.3. Neurovascular Microcatheter Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Diagnostic Delivery
    • 5.5.1. Diagnostic Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Therapeutic Embolization Delivery
    • 5.6.1. Therapeutic Embolization Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Temporary Occlusion / Flow Control
    • 5.7.1. Temporary Occlusion / Flow Control Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Vascular Access & Navigation
    • 5.8.1. Vascular Access & Navigation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurovascular Microcatheter Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Neurovascular Microcatheter Market: End Use Movement Analysis
  • 6.3. Neurovascular Microcatheter Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Clinics
    • 6.6.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ambulatory Surgical Centers
    • 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Diagnostic Centers
    • 6.8.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurovascular Microcatheter Market: Regional Estimates & Trend Analysis, by Type, by Application, and by End Use

  • 7.1. Regional Dashboard
  • 7.2. Regional Neurovascular Microcatheter Market Movement Analysis & Market Share, 2025 & 2033
  • 7.3. Neurovascular Microcatheter Market: Regional Estimates & Trend Analysis
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Neurovascular Microcatheter Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Share Analysis, 2025
  • 8.3. Key Company Profiles
    • 8.3.1. Stryker
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Medtronic
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. MicroVention (Terumo)
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Balt
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Johnson & Johnson (Cerenovus)
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Penumbra (Boston Scientific Corporation)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Cook Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Merit Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Asahi Intecc
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Integer Holdings
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Acandis GmbH (Lauxera Capital Partners)
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. phenox GmbH (Wallaby Medical)
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
Product Code: GVR-4-68040-888-1

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 4. North America Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 5. North America Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 6. North America Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 7. U.S. Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 8. U.S. Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 10. Canada Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 11. Canada Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 12. Canada Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 13. Mexico Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 14. Mexico Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 15. Mexico Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 16. Europe Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 17. Europe Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 18. Europe Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 19. Europe Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 20. Europe Neurovascular microcatheter, by clinical indication, 2021 - 2033 (USD Million)
  • Table 21. UK Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 22. UK Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 23. UK Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 24. Germany Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 25. Germany Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 26. Germany Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 27. France Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 28. France Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 29. France Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 30. Italy Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 31. Italy Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 32. Italy Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 33. Spain Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 34. Spain Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 35. Spain Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 36. Denmark Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 37. Denmark Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 38. Denmark Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 39. Sweden Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 40. Sweden Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 41. Sweden Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 42. Norway Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 43. Norway Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 44. Norway Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 45. Asia Pacific Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 46. Asia Pacific Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 49. China Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 50. China Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 51. China Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 52. Japan Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 53. Japan Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 54. Japan Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 55. India Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 56. India Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 57. India Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 58. South Korea Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 59. South Korea Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 60. South Korea Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 61. Australia Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 62. Australia Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 63. Australia Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 64. Thailand Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 65. Thailand Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 66. Thailand Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 67. Latin America Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 68. Latin America Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 69. Latin America Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 70. Latin America Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 71. Brazil Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 72. Brazil Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 73. Brazil Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 74. Argentina Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 75. Argentina Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 76. Argentina Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 77. Middle East & Africa Neurovascular microcatheter, by country, 2021 - 2033 (USD Million)
  • Table 78. Middle East & Africa Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 81. South Africa Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 82. South Africa Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 83. South Africa Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 84. Saudi Arabia Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 85. Saudi Arabia Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 87. UAE Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 88. UAE Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 89. UAE Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)
  • Table 90. Kuwait Neurovascular microcatheter, by type, 2021 - 2033 (USD Million)
  • Table 91. Kuwait Neurovascular microcatheter, by application, 2021 - 2033 (USD Million)
  • Table 92. Kuwait Neurovascular microcatheter, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Neurovascular Microcatheter Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Swot Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Neurovascular Microcatheter Market, Type Outlook Key Takeaways (USD Million)
  • Fig. 12 Neurovascular Microcatheter Market, Type Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 13 Single-Lumen Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Dual-Lumen Balloon Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Neurovascular Microcatheter Market, Application Outlook Key Takeaways (USD Million)
  • Fig. 16 Neurovascular Microcatheter Market, Application Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 17 Diagnostic Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Therapeutic Embolization Delivery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Temporary Occlusion / Flow Control Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Vascular Access & Navigation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Neurovascular Microcatheter Market, End Use Outlook Key Takeaways (USD Million)
  • Fig. 23 Neurovascular Microcatheter Market, End Use Movement Analysis 2025 & 2033 (USD Million)
  • Fig. 24 Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Neurovascular Microcatheter Market Regional Outlook, 2025 & 2033 (USD Million)
  • Fig. 29 North America Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 US Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Canada Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Mexico Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Europe Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 UK Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Germany Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 France Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Spain Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Italy Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Sweden Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Norway Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Denmark Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Asia Pacific Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 China Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Japan Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 India Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 South Korea Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Australia Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Thailand Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Latin America Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Brazil Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Argentina Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Middle East And Africa Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 South Africa Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Saudi Arabia Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 UAE Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Kuwait Neurovascular Microcatheter Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 List Of Key Emerging Company's/Product Type Disruptors/Innovators
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!